Patents
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
09/2003
09/18/2003WO2003076374A1 PROCESS FOR PRODUCING trans-4-AMINO-1-CYCLOHEXANECARBOXYLIC ACID DERIVATIVE
09/18/2003WO2003075924A1 Heterocyclic amide derivatives for the treatment of diabetes and other diseases
09/18/2003WO2003075922A1 Nitrogen monoxide synthase inhibitors
09/18/2003WO2003075858A2 Bicyclic heterocycles for the treatment of diabetes and other diseases
09/18/2003WO2003075857A2 Amino-methyl substituted tetracycline compounds
09/18/2003WO2003075853A2 Cyclic derivatives as modulators of chemokine receptor activity
09/18/2003WO2003075836A2 Cathepsin cysteine protease inhibitors
09/18/2003WO2003053915A3 Compounds for the treatment of inflammatory disorders
09/18/2003WO2003053368A3 Chalcone derivatives and their use to treat diseases
09/18/2003US20030176710 1,3-dioxane compounds containing oxo group
09/18/2003US20030176708 Thiophene substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors
09/18/2003US20030176701 Di-or triaza-spiro [4,5] decane derivatives
09/18/2003US20030176695 Such as N-(4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-2-methyl-isonicotinamide for treatment of disorders of the central nervous system; neuroprotectants
09/18/2003US20030176485 Calcium receptor active compounds
09/18/2003US20030176476 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
09/18/2003US20030176474 Modulators of Rho C activity
09/18/2003US20030176473 For use in cancer therapy
09/18/2003US20030176465 Cyclic amino acid derivatives
09/18/2003US20030176454 N-coating heterocyclic compounds
09/18/2003US20030176447 For therapy of cardiovascular diseases such as atrial and ventricular arrhythmias, intermittent claudication, Prinzmetal's (variant) angina, stable and unstable angina, exercise induced angina, congestive heart disease
09/18/2003US20030176419 As inhibitors of the retinoic acid-metabolism, as drugs
09/18/2003US20030176417 Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium compounds
09/18/2003US20030176412 2-substituted thiazolidinones as beta-3 adrenergic receptor agonists
09/18/2003US20030176318 Administering a therapeutically effective amount of a temporary p53 inhibitor to an individual suffering from the disease or condition
09/18/2003CA2478921A1 Novel chalcone derivatives and uses thereof
09/18/2003CA2478765A1 Bicyclic heterocycles for the treatment of diabetes and other diseases
09/18/2003CA2478342A1 Heterocyclic amide derivatives for the treatment of diabetes and other diseases
09/17/2003EP1344771A1 2-alkoxy-phenylsulphonic acid derivatives as intermediates for herbicidal sulphonylamino(thio)carbonyl compounds
09/17/2003EP1344525A1 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
09/17/2003EP1343775A2 Piperazine derivatives
09/17/2003EP1343773A1 Thiazole derivatives for traeing ppar related disorders
09/17/2003EP1343772A1 Thia- and oxazoles and their use as ppars activators
09/17/2003EP1343561A1 Serine protease inhibitors
09/17/2003EP1314426A9 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
09/17/2003EP1230230B1 Indeno-dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments
09/17/2003EP1042327B1 A process for the reduction of oxiranyl epothilones to olefinic epothilones
09/17/2003EP0959906B1 Delta 1,6 bicyclo [4,4,0] functional dyes for contrast enhancement in optical imaging
09/17/2003EP0906293B1 Substituted sulphonyl amino(thio)carbonyl compounds and their use as herbicides
09/17/2003CN1443177A Alpha-acyl and alpha-heteroatom-substituted benzene acetamide glucokinase activators
09/17/2003CN1443169A Chemical process for extraction of 2-hydroxy pyridine derivatives, 2-hydroxyquinoline, and 2-hydroxybenzothiazole
09/17/2003CN1443155A Compounds to treat alzheimer's disease
09/17/2003CN1443068A Combinations of depepotidyl peptidase IV inhibitors and other antidiabetic agents for treatment of diabete mellitus
09/17/2003CN1121401C Aminophenol derivates
09/17/2003CN1121379C Synthesis and use of retinene derivative having negative hormone and/or antagonist activities
09/17/2003CN1121376C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives and matrix metalloprotease inhibitors
09/16/2003US6620841 Furan or benzofuran derivatives substituted with triazole; acquired immunodeficiency syndrome (AIDS)
09/16/2003US6620830 Certain thiazolidinedione, oxadiazolidinedione, and triazolone compounds which are thyroid receptor ligands
09/16/2003US6620828 Antiproliferative agents
09/16/2003US6620813 Hydroxamate derivatives of non-steroidal anti-inflammatory drugs
09/16/2003US6620767 Pesticidal n-heteroaryl alpha-alkoximino-carboxamides
09/16/2003CA2085802C 5,6-disubstituted-3-pyridylmethyl ammonium halide compounds useful for the preparation of 5-(substituted methyl) -2,3-pyridinedicarboxylic acids
09/16/2003CA2069165C Stabilization of aqueous hydroxylamine solutions
09/16/2003CA2068089C Method and compositions for using non-ionic contrast agents to reduce the risk of clot formulation in diagnostic procedures
09/12/2003WO2003074521A1 Derivatives of epothilone b and d and synthesis thereof
09/12/2003WO2003074504A2 Process and intermediates for preparing phenylthiomethyl-thiazoles or oxazoles
09/12/2003WO2003074495A1 Hppars activators
09/12/2003WO2003074491A1 O-cyclopropyl-carboxanilides and their use as fungicides
09/12/2003WO2003074475A2 Substituted aryl ketones
09/12/2003WO2003074052A1 Thiazole and oxazole derivatives that modulate ppar activity
09/12/2003WO2003074051A1 Substituted thiazoles and oxazoles that modulate ppar activity
09/12/2003WO2003074050A1 Thiazole and oxazole derivatives which modulate ppar activity
09/12/2003CA2478520A1 Thiazole and oxazole derivatives which modulate ppar activity
09/12/2003CA2478164A1 Substituted thiazoles and oxazoles that modulate ppar activity
09/12/2003CA2476580A1 Thiazole and oxazole derivatives that modulate ppar activity
09/11/2003US20030171596 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
09/11/2003US20030171591 Process for producing optically active sulfoxide derivative
09/11/2003US20030171411 Amide derivatives as therapeutic agents
09/11/2003US20030171399 Quinolinyl and benzothiazolyl modulators
09/11/2003US20030171377 Therapy for non-insulin dependent diabetes
09/11/2003US20030171349 Novel muscarinic receptor agonists
09/11/2003US20030171213 Catalyst system and a process for the preparation of a nonracemic chiral alcohol by hydrogenation of a ketone using the catalyst system, wherein the catalyst system comprises ruthenium, a nonracemic chiral diphosphine ligand, an
09/11/2003US20030170381 Piezoelectric element and process for production thereof
09/11/2003US20030168970 Luminescent element material and luminescent element comprising the same
09/10/2003EP1341779A2 Heterocyclic sulfonamide inhibitors of beta amyloid production
09/10/2003EP1341776A1 Benzazolonylcarbonyl cyclohexenones and use thereof as herbicides
09/10/2003EP1341774A1 Fused heteroaromatic glucokinase activators
09/10/2003EP1341771A2 Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors
09/10/2003EP1341534A2 Compounds having fungicidal activity and processes to make and use same
09/10/2003EP1135388B1 3-(heterocyclyl)-substituted benzoylpyrazols
09/10/2003EP0873341B1 Epothilone derivatives, preparation and use
09/10/2003EP0851862B1 1(hetero)aryl-4-(condensed thiazol-2-ylalkyl)-piperazine derivatives, their preparation and their use in the treatment of 5-ht1a-receptor mediated disorders
09/10/2003CN1441800A Beta 3 adrenergic agonists
09/10/2003CN1441673A 4,5-dihydro-thiazo-2-ylamine derivatives and their use as NO-synthase inhibitors
09/10/2003CN1440971A Vitronectin receptor antagnist, its preparation and use
09/10/2003CN1440966A Naphthaquinone thiazole as organic as third-order non-linear optical material and its chemical synthesis process
09/09/2003US6617460 Process for preparing toluenesulfinates
09/09/2003US6617341 Insecticidal 2-iminothiazole derivatives
09/09/2003CA2031480C Acetylenes disubstituted with a heteroaromatic group and a substituted phenyl group having retinoid like activity
09/04/2003WO2003072577A1 Thiazole derivatives as npy receptor antagonists
09/04/2003WO2003072557A1 5-phenylthiazole derivatives and use as pi3 kinase inhibitors
09/04/2003WO2003072556A1 Glutaminyl based dpiv inhibitors
09/04/2003WO2003072554A1 Azole compounds
09/04/2003WO2003072535A2 Substituted hydroxyethylamines
09/04/2003WO2003072532A1 Ester compound and medicinal use thereof
09/04/2003WO2003072528A2 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
09/04/2003WO2003072102A1 Peroxisome proliferator activated receptor modulators
09/04/2003WO2003072101A1 2-methylthiazolidine-2,4-dicarboxylic acid and the salts thereof used for the treatment of neurodegenerative diseases
09/04/2003WO2003072100A1 Peroxisome proliferator activated receptor modulators
09/04/2003WO2003053367A3 Hydrogenation of precursors to thiazolidinedione antihyperglycemics
09/04/2003WO2002070468A3 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity